Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Poxel SA (POXEL) Price & Analysis

POXEL Stock Chart & Stats

€0.17-€0.01(-3.51%)
At close: 4:00 PM EDT
EUR 0.15EUR 0.23 Aug17 Aug31 Aug14 Sep28 Sep12 Oct26 Oct
Day’s Range
EUR 0.16 - EUR 0.17
52-Week Range
EUR 0.13 - EUR 0.48
Previous Close
EUR 0.17
Volume
292.16K
Average Volume (3M)
999.56K
Market Cap
EUR 8.87M
Enterprise Value
EUR 85.28M
Total Cash (Recent Filing)
EUR 2.06M
Total Debt (Recent Filing)
EUR 60.99M
Price to Earnings (P/E)
―
Beta
0.08
Next Earnings
Mar 24, 2027
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Commercial Partnership With Sumitomo Pharma

A revenue-generating, arm’s-length commercialization partnership in Japan provides durable non-dilutive cash via milestones/royalties and shifts commercialization burden to an established local partner. This reduces short-term capex needs and supports predictable collaboration receipts over coming quarters.

Sharp Revenue Rebound In 2024

A material revenue inflection indicates commercial traction for marketed products or recognition of partnership receipts. Sustained top-line recovery over multiple quarters would improve operating leverage potential and validate the commercial model versus purely pre-revenue peers.

Focused Metabolic/NASH Clinical Pipeline

A coherent R&D focus on diabetes and NASH leverages prior regulatory/commercial experience with imeglimin and targets large, structural markets. Small‑molecule assets can be more cost-efficient to develop and attract partnering/licensing opportunities, supporting multiple long-term value pathways.

Bears Say

Highly Stressed Balance Sheet

Deep negative equity combined with rising debt materially limits financial flexibility, increasing refinancing and dilution risk. Over a multi‑month horizon this constrains runway for R&D and commercialization investments and raises the probability management must seek costly external funding.

Persistent Negative Operating Cash Flow

Sustained negative operating cash flow means the company cannot self-fund growth and depends on partners, milestone receipts, or financing. That reliance impairs long‑term planning, elevates dilution risk, and could limit ability to scale commercialization or fund pivotal trials without external capital.

Ongoing Unprofitability And Volatile Margins

Despite revenue gains, persistent negative profitability and historical margin swings indicate weak operating leverage and unstable unit economics. Over the medium term, sustainable value creation depends on consistent margin recovery and cost control, which are not yet demonstrated.

Poxel SA News

POXEL FAQ

What was Poxel SA’s price range in the past 12 months?
Poxel SA lowest stock price was €0.13 and its highest was €0.48 in the past 12 months.
What is Poxel SA’s market cap?
Poxel SA’s market cap is €8.87M.
When is Poxel SA’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Poxel SA’s earnings last quarter?
Poxel SA released its earnings results on Sep 23, 2025. The company reported -€0.049 earnings per share for the quarter.
Is Poxel SA overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Poxel SA pay dividends?
Poxel SA does not currently pay dividends.
What is Poxel SA’s EPS estimate?
Poxel SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Poxel SA have?
Poxel SA has 53,758,167 shares outstanding.
What happened to Poxel SA’s price movement after its last earnings report?
Poxel SA reported an EPS of -€0.049 in its last earnings report. Following the earnings report the stock price went down -8.718%.
Which hedge fund is a major shareholder of Poxel SA?
Currently, no hedge funds are holding shares in FR:POXEL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology